FAST NEWS: CanSino’s revenue plunges as demand dries up for Covid vaccines
The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) announced on Wednesday it recorded a net loss of 1.28 billion yuan ($176 million) in the first half of this year, reversing a 16.04…
FAST NEWS: CanSino Spends $21 Million on Share Buyback
The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) said Friday it bought back about 670,000 of its Shanghai-listed A-shares for 147 million yuan ($20.8 million) as of Nov. 30, accounting for…
FAST NEWS: CanSino’s Inhaled Covid Booster Gets China Green Light
The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) announced on Sunday that China’s National Medical Products Administration (NMPA) have given emergency use authorization for its inhaled recombinant Covid-19 vaccine for use as…
CanSino’s Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?
The company’s Convidecia has received emergency-use authorization from the World Health Organization, becoming the third Chinese vaccine to get that nod Key Takeaways: CanSino’s Covid-19 vaccine Convidecia will be admitted…
FAST NEWS: Covid Vaccine Boosts CanSino to Profitability
The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) said late Thursday its revenue rose 7% year-on-year to about 500 million yuan ($75.5 million) in the first quarter of this year, as…
FAST NEWS: CanSino’s Covid Vaccine Approved for Boosters in China
The latest: CanSino Biologics Inc. (6185.HK) announced on Sunday that its recombinant novel coronavirus vaccine Convidecia has been approved for use in China in a “mixed” booster vaccination program to…
Recent Articles
RELATED ARTICLES
-
Dispute over Covid vaccines casts doubt on Clover Bio recovery
2197.HK -
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising
ZYBT.US
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
WuXi Biologics sells vaccine plant as new U.S. law looms
2269.HK
-
Yan Palace flies back to profit growth as revenue sags
1497.HK
